BioRestorative Therapies (BRTX) News Today $1.80 -0.17 (-8.42%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.80 0.00 (0.00%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease ProgramFebruary 20 at 8:30 AM | globenewswire.comContrasting BioRestorative Therapies (NASDAQ:BRTX) & Quipt Home Medical (NASDAQ:QIPT)February 13, 2025 | americanbankingnews.comRoth Capital Brokers Decrease Earnings Estimates for BRTXFebruary 12, 2025 | americanbankingnews.comBioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease ProgramDecember 5, 2024 | globenewswire.comBioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comBioRestorative Therapies to Announce Phase 2 Trial DataNovember 7, 2024 | markets.businessinsider.comBioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumNovember 6, 2024 | markets.businessinsider.comBioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthNovember 5, 2024 | globenewswire.comBioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor EventsOctober 10, 2024 | markets.businessinsider.comBioRestorative Therapies (NASDAQ:BRTX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comBioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceOctober 3, 2024 | globenewswire.comBioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 DrugsSeptember 19, 2024 | globenewswire.comBioRestorative Therapies, Inc: BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | finanznachrichten.deBioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational MedicineJuly 23, 2024 | sg.finance.yahoo.comBioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational MedicineJuly 23, 2024 | globenewswire.comBioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease ProgramJune 27, 2024 | globenewswire.comBioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial ResultsJune 17, 2024 | globenewswire.comWhy Is BioRestorative Therapies (BRTX) Stock Up 42% Today?June 13, 2024 | investorplace.comWhy Is BioRestorative Therapeutics (BRTX) Stock Up 42% Today?June 13, 2024 | investorplace.comBioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease ProgramJune 13, 2024 | globenewswire.comBioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare ConferenceJune 4, 2024 | globenewswire.comBioRestorative Therapies, Inc: BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance NoticeMay 25, 2024 | finanznachrichten.deBioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance NoticeMay 24, 2024 | globenewswire.comBioRestorative Therapies reports Q1 resultsMay 17, 2024 | seekingalpha.comBioRestorative Therapies, Inc: BioRestorative Therapies Provides First Quarter 2024 Business UpdateMay 15, 2024 | finanznachrichten.deBioRestorative Therapies Provides First Quarter 2024 Business UpdateMay 14, 2024 | globenewswire.comBioRestorative Therapies, Inc: BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting ObesityMay 8, 2024 | finanznachrichten.deBioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting ObesityMay 8, 2024 | globenewswire.comBioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024April 30, 2024 | globenewswire.comBioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics TechnologyApril 30, 2024 | globenewswire.comBioRestorative Therapies, Inc: BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentApril 16, 2024 | finanznachrichten.deBiotech Catches Major Premarket Bid Following FDA ClearanceApril 16, 2024 | theglobeandmail.comBioRestorative Therapies Shares Rise 17% After FDA Clears Phase 2 Study Protocol AmendmentApril 16, 2024 | marketwatch.comBioRestorative gains as FDA clears amendment to study on cell therapy candidateApril 16, 2024 | msn.comBioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentApril 16, 2024 | globenewswire.comBioRestorative Therapies VP buys shares worth over $10,000April 12, 2024 | investing.comBioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseApril 8, 2024 | globenewswire.comBioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsApril 3, 2024 | globenewswire.comBioRestorative Therapies Full Year 2023 Earnings: Beats ExpectationsApril 3, 2024 | finance.yahoo.comBioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KApril 1, 2024 | globenewswire.comBioRestorative engages advisory firm for clinical application of cell therapy BRTX-100March 12, 2024 | msn.comBioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceMarch 11, 2024 | globenewswire.comFavourable Signals For BioRestorative Therapies: Numerous Insiders Acquired StockFebruary 15, 2024 | finance.yahoo.comBioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual MeetingFebruary 14, 2024 | finance.yahoo.comBioRestorative Therapies Sparks Investor Interest with New TransactionFebruary 9, 2024 | msn.comBioRestorative Therapies Secures $8.1M Through Warrant RestructuringFebruary 9, 2024 | msn.comShares of BioRestorative Therapies Fall to Four-Year Low on Exercise of Warrants, New IssueFebruary 6, 2024 | marketwatch.comWhy BioRestorative Therapies (BRTX) Stock Is Down 55%February 6, 2024 | msn.comBioRestorative Therapies Clarifies Disclosure Liability LimitsFebruary 6, 2024 | msn.comBioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketFebruary 6, 2024 | finance.yahoo.com Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BRTX Media Mentions By Week BRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BRTX News Sentiment▼0.000.60▲Average Medical News Sentiment BRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BRTX Articles This Week▼10▲BRTX Articles Average Week Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Enzo Biochem News Today Concord Medical Services News Today NewGenIvf Group News Today Kindly MD News Today Marpai News Today Mangoceuticals News Today OpGen News Today SunLink Health Systems News Today Vsee Health News Today Ontrak News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BRTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRTX Stock Alerts